Find link

language:

Find link is a tool written by Edward Betts.

searching for Taiho Pharmaceutical 8 found (18 total)

Pimitespib (167 words) [view diff] exact match in snippet view article find links to article

gastrointestinal stromal tumors. It was discovered and developed by Taiho Pharmaceutical Co. The mechanism of action of pimitespib involves inhibition of

Futibatinib (555 words) [view diff] exact match in snippet view article find links to article

on 4 October 2022. Retrieved 4 October 2022 – via PR Newswire. "Taiho Pharmaceutical Obtains Approval in Japan to Manufacture and Market FGFR Inhibitor

Astex Pharmaceuticals (1,106 words) [view diff] exact match in snippet view article find links to article

target – either through inhibition or activation. In 2020, Astex and Taiho Pharmaceutical Co., Ltd. entered into a new partnership with Merck & Co., Inc.,

Suplatast tosilate (350 words) [view diff] exact match in snippet view article find links to article

composiitons containing the same", issued 1985-12-03, assigned to Taiho Pharmaceutical Co Ltd "Suplatast tosilate". Thieme. Retrieved 2024-07-03. "Suplatast

1983 Japanese Regional Leagues (130 words) [view diff] exact match in snippet view article find links to article

Club 16 5 4 7 32 36 −4 14 7 Imabari Club 16 5 2 9 35 42 −7 12 8 Showa Club 16 4 2 10 34 42 −8 10 9 Taiho Pharmaceutical 16 1 2 13 15 82 −67 4 Relegated

1982 Japanese Regional Leagues (152 words) [view diff] exact match in snippet view article find links to article

14 6 2 6 30 34 −4 14 6 Otsuka Pharmaceuticals 14 6 1 7 27 32 −5 13 7 Takasho OB Club 14 5 3 6 19 26 −7 13 8 Taiho Pharmaceutical 14 1 2 11 18 38 −20 4

Grindeks (1,358 words) [view diff] exact match in snippet view article find links to article

signed with Japanese pharmaceutical companies Iskra Industry and Taiho Pharmaceutical to supply the anti-cancer agent Ftorafur® and it spreads the fame

Decitabine/cedazuridine (1,175 words) [view diff] exact match in snippet view article find links to article

agent (HMA) therapy for intermediate and high-risk MDS and CMML". Taiho Pharmaceutical Group (Press release). 7 July 2020. Archived from the original on